APA

Wei Y., Chen R., Dimicoli S., Bueso-Ramos C., Neuberg D., Pierce S., Wang H., Yang H., Jia Y., Zheng H., Fang Z., Nguyen M., Ganan-Gomez I., Ebert B., Levine R., Kantarjian H. & Garcia-Manero G. (20140109). Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. : Leukemia.

Chicago

Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, Wang H, Yang H, Jia Y, Zheng H, Fang Z, Nguyen M, Ganan-Gomez I, Ebert B, Levine R, Kantarjian H and Garcia-Manero G. 20140109. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. : Leukemia.

Harvard

Wei Y., Chen R., Dimicoli S., Bueso-Ramos C., Neuberg D., Pierce S., Wang H., Yang H., Jia Y., Zheng H., Fang Z., Nguyen M., Ganan-Gomez I., Ebert B., Levine R., Kantarjian H. and Garcia-Manero G. (20140109). Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. : Leukemia.

MLA

Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, Wang H, Yang H, Jia Y, Zheng H, Fang Z, Nguyen M, Ganan-Gomez I, Ebert B, Levine R, Kantarjian H and Garcia-Manero G. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. : Leukemia. 20140109.